Dr. Burris Discusses Targeting the mTOR Pathway

onclivetv has 407 videos Subscribe Here

Description: Visit to view more

Howard A. "Skip" Burris, III, MD, chief medical officer and executive director, Drug Development Program, Sarah Cannon Research Institute in Nashville, Tennessee, discusses successful clinical applications for the inhibition of the mammalian target of rapamycin (mTOR) pathway.

For the full description visit
Shared By : onclivetv
Posted on : 02/01/12
Added : 6 years ago
Category : General


Nothing found.

More From onclivetv

Nothing found.